Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease
This study is currently recruiting participants.
Verified December 2012
by Department of Veterans Affairs
Study NCT00892450 Information provided by Department of Veterans Affairs
First Received on April 28, 2009. Last Updated on December 3, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Parkinson's Disease
Overactive Bladder
Additional conditions recognized in this trial
Parkinson Disease
Urinary Bladder, Overactive
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders
Signs and Symptoms
Urinary Bladder Diseases
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
Oxybutynin and darifenacin
Additional drug interventions recognized in this trial
Cholinergic Antagonists
Darifenacin
Oxybutynin
More general drug interventions related to this trial
Autonomic Agents
Cholinergic Agents
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Department of Veterans Affairs
Back to top of Main Content
